Identification of Risk Factors for and Development of a Predictive Model for Immunotherapy-Associated Venous Thromboembolism (VTE) in Patients with Non-Small Cell Lung Cancer
Publication
, Conference
Sanfilippo, KM; Luo, S; Lyman, GH; Calverley, DC; Kuderer, DNMM
Published in: Blood
November 15, 2022
Duke Scholars
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 15, 2022
Volume
140
Issue
Supplement 1
Start / End Page
2803 / 2804
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Sanfilippo, K. M., Luo, S., Lyman, G. H., Calverley, D. C., & Kuderer, D. N. M. M. (2022). Identification of Risk Factors for and Development of a Predictive Model for Immunotherapy-Associated Venous Thromboembolism (VTE) in Patients with Non-Small Cell Lung Cancer. In Blood (Vol. 140, pp. 2803–2804). American Society of Hematology. https://doi.org/10.1182/blood-2022-165748
Sanfilippo, Kristen M., Suhong Luo, Gary H. Lyman, David C. Calverley, and Dr Nicole M. M. Kuderer. “Identification of Risk Factors for and Development of a Predictive Model for Immunotherapy-Associated Venous Thromboembolism (VTE) in Patients with Non-Small Cell Lung Cancer.” In Blood, 140:2803–4. American Society of Hematology, 2022. https://doi.org/10.1182/blood-2022-165748.
Sanfilippo KM, Luo S, Lyman GH, Calverley DC, Kuderer DNMM. Identification of Risk Factors for and Development of a Predictive Model for Immunotherapy-Associated Venous Thromboembolism (VTE) in Patients with Non-Small Cell Lung Cancer. In: Blood. American Society of Hematology; 2022. p. 2803–4.
Sanfilippo, Kristen M., et al. “Identification of Risk Factors for and Development of a Predictive Model for Immunotherapy-Associated Venous Thromboembolism (VTE) in Patients with Non-Small Cell Lung Cancer.” Blood, vol. 140, no. Supplement 1, American Society of Hematology, 2022, pp. 2803–04. Crossref, doi:10.1182/blood-2022-165748.
Sanfilippo KM, Luo S, Lyman GH, Calverley DC, Kuderer DNMM. Identification of Risk Factors for and Development of a Predictive Model for Immunotherapy-Associated Venous Thromboembolism (VTE) in Patients with Non-Small Cell Lung Cancer. Blood. American Society of Hematology; 2022. p. 2803–2804.
Published In
Blood
DOI
EISSN
1528-0020
ISSN
0006-4971
Publication Date
November 15, 2022
Volume
140
Issue
Supplement 1
Start / End Page
2803 / 2804
Publisher
American Society of Hematology
Related Subject Headings
- Immunology
- 3213 Paediatrics
- 3201 Cardiovascular medicine and haematology
- 3101 Biochemistry and cell biology
- 1114 Paediatrics and Reproductive Medicine
- 1103 Clinical Sciences
- 1102 Cardiorespiratory Medicine and Haematology